Logo image of PMBC

Pacific Mercantile (PMBC) Stock Fundamental Analysis

NASDAQ:PMBC - Nasdaq -

9.4  -0.11 (-1.16%)

Fundamental Rating

2

PMBC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 393 industry peers in the Banks industry. PMBC may be in some trouble as it scores bad on both profitability and health. PMBC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PMBC was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 1.05%
ROE 9.66%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PMBC does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 26.65%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for PMBC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PMBC has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

5

3. Growth

3.1 Past

PMBC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 857.14%, which is quite impressive.
PMBC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.96% yearly.
The Revenue has grown by 9.54% in the past year. This is quite good.
PMBC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.00% yearly.
EPS 1Y (TTM)857.14%
EPS 3Y-8.04%
EPS 5Y-7.96%
EPS Q2Q%87.5%
Revenue 1Y (TTM)9.54%
Revenue growth 3Y6.62%
Revenue growth 5Y10%
Sales Q2Q%0.53%

3.2 Future

PMBC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.96% yearly.
PMBC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.18% yearly.
EPS Next Y-34.55%
EPS Next 2Y-31.07%
EPS Next 3Y41.82%
EPS Next 5Y29.96%
Revenue Next Year2.96%
Revenue Next 2Y3.99%
Revenue Next 3Y-1.34%
Revenue Next 5Y-1.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PMBC Yearly Revenue VS EstimatesPMBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PMBC Yearly EPS VS EstimatesPMBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.03 indicates a correct valuation of PMBC.
PMBC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.85, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 56.52, the valuation of PMBC can be described as expensive.
PMBC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.98.
Industry RankSector Rank
PE 14.03
Fwd PE 56.52
PMBC Price Earnings VS Forward Price EarningsPMBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMBC Per share dataPMBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PMBC's earnings are expected to grow with 41.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-31.07%
EPS Next 3Y41.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PMBC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Pacific Mercantile

NASDAQ:PMBC (10/18/2021, 8:12:58 PM)

9.4

-0.11 (-1.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.17%
Inst Owner Change-98.64%
Ins Owners6.37%
Ins Owner Change0%
Market Cap210.79M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.03
Fwd PE 56.52
P/S 3.5
P/FCF N/A
P/OCF N/A
P/B 1.27
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.67
EY7.13%
EPS(NY)0.17
Fwd EY1.77%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.69
BVpS7.42
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 9.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 26.65%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)857.14%
EPS 3Y-8.04%
EPS 5Y-7.96%
EPS Q2Q%87.5%
EPS Next Y-34.55%
EPS Next 2Y-31.07%
EPS Next 3Y41.82%
EPS Next 5Y29.96%
Revenue 1Y (TTM)9.54%
Revenue growth 3Y6.62%
Revenue growth 5Y10%
Sales Q2Q%0.53%
Revenue Next Year2.96%
Revenue Next 2Y3.99%
Revenue Next 3Y-1.34%
Revenue Next 5Y-1.18%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A